Rikke Nørregaard Selected Research

Ureteral Obstruction

1/2022	Increased COX-2 after ureter obstruction attenuates fibrosis and is associated with EP2 receptor upregulation in mouse and human kidney.
1/2021	Tamoxifen attenuates renal fibrosis in human kidney slices and rats subjected to unilateral ureteral obstruction.
1/2019	Vasopressin-Independent Regulation of Aquaporin-2 by Tamoxifen in Kidney Collecting Ducts.
1/2019	Metformin modulates immune cell infiltration into the kidney during unilateral ureteral obstruction in mice.
1/2019	Activation of the prostaglandin E2 EP2 receptor attenuates renal fibrosis in unilateral ureteral obstructed mice and human kidney slices.
9/2017	Pressure and stretch differentially affect proliferation of renal proximal tubular cells.
8/2017	MicroRNA-148b regulates megalin expression and is associated with receptor downregulation in mice with unilateral ureteral obstruction.
1/2017	15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction.
12/2015	Disruption of cyclooxygenase type 2 exacerbates apoptosis and renal damage during obstructive nephropathy.
6/2015	Quercetin attenuates cyclooxygenase-2 expression in response to acute ureteral obstruction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rikke Nørregaard Research Topics

Disease

26	Ureteral Obstruction 01/2022 - 08/2005
16	Fibrosis (Cirrhosis) 01/2022 - 01/2015
8	Chronic Renal Insufficiency 01/2021 - 11/2010
8	Reperfusion Injury 01/2021 - 01/2016
8	Polyuria 01/2018 - 11/2006
7	Hydronephrosis 01/2022 - 04/2011
7	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 09/2010
6	Ischemia 10/2020 - 06/2014
5	Nephrogenic Diabetes Insipidus 01/2020 - 01/2009
5	Inflammation (Inflammations) 02/2017 - 01/2014
3	Brain Death (Brain Dead) 01/2022 - 01/2014
3	Delayed Graft Function 01/2022 - 01/2014
3	Hypoxia (Hypoxemia) 01/2019 - 01/2009
2	Pyelonephritis 01/2022 - 01/2019
2	Kidney Diseases (Kidney Disease) 01/2022 - 01/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2020 - 01/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 02/2013
2	Mood Disorders (Mood Disorder) 01/2018 - 01/2018
2	Wounds and Injuries (Trauma) 10/2017 - 01/2017
2	Proteinuria 08/2017 - 11/2010
2	Shock 01/2017 - 11/2010
2	Neoplasms (Cancer) 02/2013 - 07/2012
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2021
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2021
1	Pathologic Processes 01/2020
1	Atherosclerosis 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2011
7	salicylhydroxamic acid (SHAM)IBA 08/2020 - 01/2009
7	Aquaporins (Water Channels)IBA 11/2012 - 08/2005
5	CytokinesIBA 07/2014 - 04/2012
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
4	Aquaporin 2IBA 01/2022 - 01/2009
4	Fibronectins (Fibronectin)IBA 01/2022 - 08/2020
4	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2019
4	Tamoxifen FDA LinkGeneric 01/2021 - 01/2018
4	LithiumIBA 01/2020 - 01/2018
4	SodiumIBA 07/2016 - 08/2005
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2015 - 11/2006
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2015 - 04/2010
3	CollagenIBA 01/2022 - 01/2019
3	Pyruvic Acid (Pyruvate)IBA 10/2020 - 02/2013
3	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 10/2016
3	EnzymesIBA 01/2017 - 09/2010
2	Serine (L-Serine)FDA Link 01/2022 - 01/2009
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2022 - 01/2017
2	SaltsIBA 01/2022 - 07/2011
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Streptozocin (Streptozotocin)FDA Link 10/2020 - 02/2013
2	Alanine (L-Alanine)FDA Link 10/2020 - 01/2017
2	Urea (Carbamide)FDA LinkGeneric 01/2019 - 11/2016
2	CreatinineIBA 01/2019 - 07/2014
2	Low Density Lipoprotein Receptor-Related Protein-2IBA 08/2017 - 01/2017
2	AntioxidantsIBA 01/2017 - 12/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 04/2012
2	ChemokinesIBA 07/2014 - 06/2014
2	Melanocyte-Stimulating Hormones (MSH)IBA 06/2014 - 01/2014
2	Oxygen (Dioxygen)IBA 10/2009 - 01/2009
2	candesartanIBA 02/2007 - 11/2006
1	Thromboxane B2IBA 01/2022
1	endotrophinIBA 01/2022
1	Bacterial LysatesIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Collagen Type VIIBA 01/2022
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2022
1	2-acetylhydrazide 8-chloro- Dibenz(b,f)(1,4)oxazepine- 10(11H)- carboxylic acidIBA 01/2022
1	ThromboxanesIBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 07/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 07/2021
1	linrodostatIBA 07/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Sulfhydryl Compounds (Thiols)IBA 01/2021
1	Amino Acids FDA Link 10/2020
1	Carbon-13IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	LDL CholesterolIBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Hemolysin Proteins (Hemolysins)IBA 01/2019
1	Collagen Type III (Type III Collagen)IBA 01/2019
1	Extracellular Matrix ProteinsIBA 01/2019
1	CationsIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	NitrogenIBA 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Protons (Proton)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019

Therapy/Procedure

6	Kidney Transplantation 01/2022 - 09/2012
6	Nephrectomy 01/2022 - 11/2010
2	Therapeutics 08/2020 - 05/2020
2	Cystectomy 10/2017 - 02/2017
2	Transplantation 01/2014 - 09/2012
1	Radiotherapy 01/2021